Brigatinib: A Review in ALK-Inhibitor Naïve Advanced ALK-Positive NSCLC
Sheridan M. Hoy
Topics & Concepts
CrizotinibMedicineAnaplastic lymphoma kinaseALK inhibitorCeritinibTolerabilityInternal medicineLung cancerROS1PopulationTyrosine-kinase inhibitorOncologyPharmacologyCancerAdverse effectAdenocarcinomaEnvironmental healthMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer therapeutics and mechanisms